PAN-Biotech RPMI 1640, w/o: L-Glutamine, w: 2.0 g/L NaHCO3

Introduction

RPMI 1640, also known as RPMI Medium, was originally developed at Roswell Park Memorial Institute (RPMI) in 1966 for the growth of human leukemia cells in monolayer or suspension cultures. RPMI media has since been found to be suitable for a wide variety of mammalian and hybridoma cells. We offer a variety of RPMI media to meet the needs of your specific applications.

Composition

PAN-Biotech RPMI 1640, w/o: L-Glutamine, w: 2.0 g/L NaHCO3

Specifications

Cat. No. P04-17500

Documents

• Product Composition
• Material Safety Data Sheet (MSDS)

Product References

• Abdurrahman, Goran et al. “The extracellular serine protease from Staphylococcus epidermidis elicits a type 2-biased immune response in atopic dermatitis patients.” Frontiers in immunology vol. 15 1352704. 4 Jun. 2024, doi:10.3389/fimmu.2024.1352704
• Jacques, Camille et al. “Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV^® Active Ingredients.” Life (Basel, Switzerland) vol. 14,1 102. 9 Jan. 2024, doi:10.3390/life14010102
• Álvarez-Heredia, Pablo et al. “A Straightforward Cytometry-Based Protocol for the Comprehensive Analysis of the Inflammatory Valve Infiltrate in Aortic Stenosis.” International journal of molecular sciences vol. 24,3 2194. 22 Jan. 2023, doi:10.3390/ijms24032194
• Namli, Ilayda et al. “Hydrodynamic Cavitation on a Chip: A Tool to Detect Circulating Tumor Cells.” ACS applied materials & interfaces vol. 14,36 (2022): 40688-40697. doi:10.1021/acsami.2c12356
• Yang, Xiaoli et al. “The Mycotoxin Beauvericin Exhibits Immunostimulatory Effects on Dendritic Cells via Activating the TLR4 Signaling Pathway.” Frontiers in immunology vol. 13 856230. 8 Apr. 2022, doi:10.3389/fimmu.2022.856230
• Elazezy, Maha et al. “Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer.” Cancers vol. 13,15 3869. 31 Jul. 2021, doi:10.3390/cancers13153869
• Koutník, Jiří et al. “T cell-intrinsic protein kinase D3 is dispensable for the cells' activation.” Frontiers in immunology vol. 13 1049033. 17 Nov. 2022, doi:10.3389/fimmu.2022.1049033
• Caetano-Pinto, Pedro et al. “In Vitro Characterization of Renal Drug Transporter Activity in Kidney Cancer.” International journal of molecular sciences vol. 23,17 10177. 5 Sep. 2022, doi:10.3390/ijms231710177
• Nordengrün, Maria et al. “Allergic Reactions to Serine Protease-Like Proteins of Staphylococcus aureus.” Frontiers in immunology vol. 12 651060. 23 Mar. 2021, doi:10.3389/fimmu.2021.651060
• Höper, Tessa et al. “The Contact Allergen NiSO₄ Triggers a Distinct Molecular Response in Primary Human Dendritic Cells Compared to Bacterial LPS.” Frontiers in immunology vol. 12 644700. 11 Mar. 2021, doi:10.3389/fimmu.2021.644700
• Walter, Frederik et al. “Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses.” PloS one vol. 15,9 e0239369. 30 Sep. 2020, doi:10.1371/journal.pone.0239369
• Zinggeler, Marc et al. “Biophysical Insights on the Enrichment of Cancer Cells from Whole Blood by (Affinity) Filtration.” Scientific reports vol. 9,1 1246. 4 Feb. 2019, doi:10.1038/s41598-018-37541-3
• Steuer, Anna et al. “Cell stimulation versus cell death induced by sequential treatments with pulsed electric fields and cold atmospheric pressure plasma.” PloS one vol. 13,10 e0204916. 12 Oct. 2018, doi:10.1371/journal.pone.0204916
• Gaebler, Anne et al. “Alkyne lipids as substrates for click chemistry-based in vitro enzymatic assays.” Journal of lipid research vol. 54,8 (2013): 2282-2290. doi:10.1194/jlr.D038653

Ilex Life Sciences LLC is an authorized distributor of PAN-Biotech products.